Josh Blacher is the Chief Financial Officer at BullFrog AI Holdings, Inc., bringing over two decades of financial leadership in the life sciences and biotech sectors. He specializes in financial strategy, capital raising, and corporate development for both private and public companies.
Prior Experience:
• Chief Financial Officer & Chief Business Officer – RNA Disease Diagnostics
• Chief Financial Officer – InMed Pharmaceuticals, Therapix Biosciences, Galmed Pharmaceuticals
• Corporate Development – Columbus Circle Capital, Teva Pharmaceuticals
• Investment Management – Deutsche Asset Management, Morgan Stanley
Mr. Blacher earned a Bachelor of Arts in Economics from Yeshiva University and an MBA in Finance from Columbia Business School. His extensive experience in financial stewardship and strategic growth supports BullFrog AI’s mission to advance AI-driven drug discovery.